InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Fernandes Prabhavathi, Director. Director active across 2 companies, notably Ocugen, Inc.. In total, 7 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €9k. History available since 25 May 2021. The latest transaction was filed on 26 November 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
7 of 7 declarations
Prabhavathi Fernandes is a Board Member at Ocugen, Inc. and OpGen Inc. She has experience in the biopharmaceutical sector. Her role includes overseeing operations and evaluating growth strategies.